| Micro-channel |
 |
|
|
|
|
|
| |
| Jiangxi yan dozen commercial bribery 90 days 11 medicine bribery by roll call! |
| |
| Author：中国铭铉 企划部 Release Time：2017-9-22 9:56:49 Number Browse：1374 |
| |
The medical network September 22 xun yan serious business bribery come! Starting in September and ending in December!
▍ crackdown in jiangxi province for a period of 3 months
On September 20, the website of jiangxi provincial bureau of industry and commerce released information. Jiangxi industrial and commercial bureau, the health and family planning commission and the food and drug administration have jointly issued the work plan for commercial bribery in the pharmaceutical circulation area of the province.
Jiangxi province is to be in September to December, special regulation medicine circulation area business bribe.
We will focus on bribery and bribery in the sales and procurement of pharmaceutical companies, pharmaceutical companies and hospitals. This time, all the names of the bribery in jiangxi are listed.
▍ 11 kinds of recessive bribes, named
"Rebate" or "cash", "promotion", "saving", "advertising", "KeYanFei", "system", "charge", "pay fee", "paid", "commission", "sponsorship fees", or reimburse all kinds, to each other unit and individual property.
As the "order of royalties", "prescription fee", "new drug promotion fees", "clinical observation fees" in the name of or related personnel to hospital, cash and in-kind, provide domestic and international tourism, examine and so on, are included in the category of commercial bribery.
The implicit form of bribery in the 11th is a three-month period in jiangxi province. From this document, the "secret" of drug promotion in hospitals is in the eyes of regulators.
▍ check list for 2 years of bribery, correct decently, don't change strictly
The plan calls for various pharmaceutical companies, pharmaceutical companies and hospitals in jiangxi province to conduct self-examination on the contents of the regulation by September 30.
Since 2015, we have asked pharmaceutical companies and pharmaceutical companies to examine the various violations of business ethics and market rules so far in 2015 to affect unfair competition. Hospitals and doctors are required to check the various bribery practices since 2015.
Finally, the document in jiangxi shows the attitude: the above units, which have been detected and corrected, are lighter or exempt from punishment; If you refuse to check your own right, cover up the problem or do your own thing, you will be treated with severity.
|
| |
Previous article：Another domestic drug sold to us domestic drug companies went abroad
Next article：30 billion anti-dementia drug market hospital, Top 10
|
| |
|
|
